DeePathology.ai

Company Overview

Snapshot

Founded in September 2018 by Chen Sagiv, Nizan Sagiv, and Jacob Gildenblat, DeePathology.ai operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing AI-based decision-support systems for digital pathology. In December 2019, DeePathology.ai announced a technical partnership and solution integration with Inspirata.

Business overview

DeePathology.ai develops an artificial intelligence (AI) powered decision-support system specifically for digital pathology. The company's proprietary AI technology enables rapid and accurate implementation of AI solutions for various digital pathology challenges, including helicobacter pylori detection in gastric biopsies, plaque detection in brain biopsies, and lymphocyte detection. DeePathology.ai offers cell-detection and tissue-segmentation solutions, empowering pathologists and researchers to create their own AI-based tools without requiring AI expertise. Its solutions are currently integrated into the workflows of pathologists in various European locations, serving the Health Tech & Life Sciences sector, particularly in Digital Healthcare and Medical Decision Support.

Strategic signal

In December 2019, DeePathology.ai announced a technical partnership and solution integration with Inspirata. This collaboration signals a strategic move to integrate its AI-based pathology decision-support system into broader digital pathology workflows, enhancing its market reach and validating its technology within the industry. For investors, this indicates a focus on strategic alliances to accelerate product adoption and expand its footprint in the digital healthcare market.

Company Intelligence Q&A

What is DeePathology.ai's core offering?

DeePathology.ai develops an artificial intelligence (AI) based decision-support system for digital pathology, providing solutions for problems such as helicobacter pylori detection, plaque detection, and lymphocyte detection.

When was DeePathology.ai founded?

DeePathology.ai was founded in September 2018.

Who are the founders of DeePathology.ai?

DeePathology.ai was founded by Chen Sagiv, Nizan Sagiv, and Jacob Gildenblat.

What significant partnership did DeePathology.ai announce?

In December 2019, DeePathology.ai announced a technical partnership and solution integration with Inspirata.

In which markets are DeePathology.ai's solutions currently used?

DeePathology.ai's solutions are currently in use in various locations across Europe, integrated into the workflow and routines of pathologists.